Effectiveness and safety of rezafungin versus caspofungin for candidaemia and invasive candidiasis: plain language summary of the STRIVE and ReSTORE studies

This Plain Language Summary of Publication article (PLSP) from Future Microbiology, highlights combined findings from the STRIVE and ReSTORE studies, which evaluated how well the new medicine rezafungin works compared to caspofungin for treating candidaemia and invasive candidiasis, fungal infections caused by Candida that commonly affect hospitalized individuals with weakened immune systems or recent surgeries.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials’ and was published in The Lancet Infectious Diseases.

Visit The Lancet using the link to read the original article.